Anpario plc (LON:ANP – Get Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 379.80 ($4.97) and traded as low as GBX 375 ($4.91). Anpario shares last traded at GBX 385 ($5.04), with a volume of 52,911 shares.
Wall Street Analysts Forecast Growth
Several analysts have commented on ANP shares. Shore Capital restated a “house stock” rating on shares of Anpario in a report on Monday, March 31st. Canaccord Genuity Group increased their price objective on shares of Anpario from GBX 380 ($4.97) to GBX 500 ($6.54) and gave the stock a “buy” rating in a research report on Tuesday, January 14th.
Anpario Stock Up 2.0 %
Anpario (LON:ANP – Get Free Report) last released its earnings results on Monday, March 31st. The company reported GBX 28.40 ($0.37) EPS for the quarter. Anpario had a return on equity of 8.74% and a net margin of 9.23%. As a group, sell-side analysts anticipate that Anpario plc will post 23.5757801 earnings per share for the current fiscal year.
Anpario Increases Dividend
The firm also recently announced a dividend, which will be paid on Friday, July 25th. Investors of record on Thursday, July 10th will be given a GBX 8 ($0.10) dividend. The ex-dividend date is Thursday, July 10th. This represents a yield of 2.09%. This is an increase from Anpario’s previous dividend of $3.25. Anpario’s dividend payout ratio (DPR) is 60.74%.
Insider Buying and Selling at Anpario
In related news, insider Marc Wilson purchased 3,778 shares of Anpario stock in a transaction that occurred on Tuesday, April 1st. The stock was purchased at an average cost of GBX 398 ($5.21) per share, with a total value of £15,036.44 ($19,681.20). Company insiders own 30.51% of the company’s stock.
About Anpario
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Featured Articles
- Five stocks we like better than Anpario
- How to Profit From Value Investing
- JPMorgan is a Buy, if You Can Handle The Volatility
- Where Do I Find 52-Week Highs and Lows?
- United States Steel’s Crash: An Unmissable Buying Opportunity
- Insider Trades May Not Tell You What You Think
- Rocket Lab Stock: Weathering the Storm, Time for a Comeback?
Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.